Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Que, Jianyu
Yuan, Kai
Gong, Yimiao
Meng, Shiqiu
Bao, Yanping
and
Lu, Lin
2020.
Raising awareness of suicide prevention during the COVID‐19 pandemic.
Neuropsychopharmacology Reports,
Vol. 40,
Issue. 4,
p.
392.
Chiappini, Stefania
Mosca, Alessio
Miuli, Andrea
Santovito, Maria Chiara
Orsolini, Laura
Corkery, John Martin
Guirguis, Amira
Pettorruso, Mauro
Martinotti, Giovanni
Di Giannantonio, Massimo
and
Schifano, Fabrizio
2021.
New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
Medicina,
Vol. 57,
Issue. 6,
p.
580.
Mougharbel, Fatima
Sampasa-Kanyinga, Hugues
Heidinger, Brandon
Corace, Kim
Hamilton, Hayley A.
and
Goldfield, Gary S.
2021.
Psychological and Demographic Determinants of Substance Use and Mental Health During the COVID-19 Pandemic.
Frontiers in Public Health,
Vol. 9,
Issue. ,
Raj, Saurabh
Ghosh, Debasruti
Singh, Tushar
Verma, Sunil K.
and
Arya, Yogesh K.
2021.
Theoretical Mapping of Suicidal Risk Factors During the COVID-19 Pandemic: A Mini-Review.
Frontiers in Psychiatry,
Vol. 11,
Issue. ,
Ghosh, Abhishek
Bn, Subodh
Sharma, Kshitiz
Roub, Fazl e
Mahintamani, Tathagata
Basu, Debasish
and
Mattoo, Surendra Kumar
2022.
How did the COVID-19 lockdown impact patients with dual diagnoses?.
Advances in Dual Diagnosis,
Vol. 15,
Issue. 3,
p.
152.
Mancheño-Velasco, Cinta
Dacosta-Sánchez, Daniel
Blanc-Molina, Andrea
Narvaez-Camargo, Marta
and
Lozano-Rojas, Óscar Martín
2022.
Changes in the Care Activity in Addiction Centers with Dual Pathology Patients during the COVID-19 Pandemic.
Journal of Clinical Medicine,
Vol. 11,
Issue. 15,
p.
4341.
Gajdics, Janka
Bagi, Otília
Farkas, Fanni
Andó, Bálint
Pribék, Ildikó
and
Lázár, Bence
2023.
The Impact of the COVID-19 Pandemic on the Severity of Alcohol Use Disorder: Significance of Dual Disorders.
International Journal of Environmental Research and Public Health,
Vol. 20,
Issue. 20,
p.
6939.
Llewellyn-Beardsley, Joy
Rennick-Egglestone, Stefan
Callard, Felicity
Pollock, Kristian
Slade, Mike
and
Edgley, Alison
2023.
“Nothing's changed, baby”: How the mental health narratives of people with multiple and complex needs disrupt the recovery framework.
SSM - Mental Health,
Vol. 3,
Issue. ,
p.
100221.
Patients with dually diagnosed mental illness and substance use disorder are at high risk for suicidal behaviour (Abroms and Sher, Reference Abroms and Sher2016). For example, substance use disorders are a significant predictor of suicide attempts in patients with bipolar disorder, and the risk of suicide in patients with co-occurring bipolar and alcohol use disorder is roughly twice than that of those without alcohol use disorder (Dalton et al., Reference Dalton, Cate–Carter, Mundo, Parikh and Kennedy2003). Patients with dual diagnosis are also more likely to have medical and neurological comorbidities, such as pain disorders and traumatic brain injuries, which further increase risk for suicidal behaviours (Abroms & Sher, Reference Abroms and Sher2016).
The COVID-19 pandemic may lead to relapse or exacerbation of pre-existing dual disorders and to the onset of new dual disorders. The COVID-19 crisis is associated with anxiety, fear of contagion, uncertainty, social isolation, chronic stress, economic difficulties, and other psychosocial issues which may lead to relapse or worsening of depressive, anxiety, substance use, and other psychiatric disorders in vulnerable populations, especially in individuals with dual disorders (Sher, Reference Sher2020). For example, a recent study in China showed that during the COVID-19 pandemic 19% of abstinent alcohol users and 25% of abstinent smokers relapsed (Sun et al., Reference Sun, Li, Bao, Meng, Sun, Schumann, Kosten, Strang, Lu and Shi2020). Also, 32% of regular alcohol drinkers increased alcohol consumption and 20% of regular smokers increased smoking during the pandemic. The American Medical Association Issue Brief published on 20 July 2020 stated that more than 35 U.S. States reported increases in opioid-related mortality during the COVID-19 pandemic (American Medical Association, 2020).
The COVID-19 pandemic may also lead to the onset of new dual disorders. Distressed, anxious, and depressed individuals may start using alcohol and drugs. It is important to note that substance use can lead to immune system, respiratory, and pulmonary alterations and may increase susceptibility to COVID-19.
Feelings of fear and anxiety may hold people back from seeking or continuing treatment for dual disorders. When psychiatric disorders go untreated, substance abuse typically worsens, and when someone starts using more drugs or alcohol, their psychiatric disorders worsen. The Coronavirus disease crisis may increase suicidality among patients with dual disorders during and after the pandemic. It is a perfect storm situation: the COVID-19 pandemic may increase suicide risk in persons with dual disorders who are already at elevated suicide risk.
To reduce suicides among individuals with dual disorders in the COVID-19 epoch we need to
improve recognition of dual disorders. Unrecognised and untreated individuals with dual disorders may be at a specially high suicide risk;
screen dual disorders patients for suicidal ideation;
adequately treat dual disorders;
prevent a relapse when the patient is in remission; this is especially important in the stressful COVID-19 era;
treat comorbid medical and neurological disorders;
provide social support; it is vital to reduce social isolation/loneliness during the COVID-19 epidemic;
provide dual disorders patients with information about suicide prevention hotlines and other available mental health resources;
reduce access to lethal means, if possible.
Psychiatric consequences of the COVID-19 disaster including increase in suicides are probably to be present for a lengthy time and peak later than the actual COVID-19 pandemic. Although suicide prevention is a very difficult task, clinicians are expected to make every effort to prevent suicide in their patients.